Roles of Prostaglandins D2 and E2 in Interleukin-1-Induced Activation of Norepinephrine Turnover in the Brain and Peripheral Organs of Rats

Abstract: Possible roles of prostaglandins (PGs) in interleukin-1 (IL-1)-induced activation of noradrenergic neurons were examined by assessing norepinephrine (NE) turnover in the brain and peripheral organs of rats. An intraperitoneal injection of human recombinant IL-1β accelerated NE turnover in the hypothalamus, spleen, lung, diaphragm, and pancreas. A similar increase in NE turnover was also observed after intracerebroventricular injection of corticotropin-releasing hormone (CRH). Pretreatment with indomethacin (cyclooxygenase inhibitor) abolished the IL-1-induced, but not the CRH-induced, increase in hypothalamic and splenic NE turnover. To elucidate which eicosanoid-cyclooxygenase product(s) is responsible for accelerating NE turnover, PGD₂, PGE₂, PGF_2α, U-46619 (stable thromboxane A₂ analogue), or carbacyclin (stable prostacyclin analogue) was administered intracerebroventricularly. Among them, PGE₂ was the only eicosanoid effective in increasing NE turnover in spleen, whereas PGD₂ was effective in the hypothalamus. The stimulative effect of PGD₂ was abolished by pretreatment with intracerebroventricular injection of a CRH antiserum. These results suggest that the action of IL-1 is mediated through PGD₂ production to activate the noradrenergic neurons in the hypothalamus, and through PGE₂ production to increase sympathetic nerve activity in spleen.